Partners XI Llc Canaan serves as Executive at Day One Biopharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Partners XI Llc Canaan has executed 14 insider transactions totaling $13.0M, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 20, 2022 involved selling 2,266 shares valued at $45.5K.
Partners XI Llc Canaan currently holds 9,077,904 shares of Day One Biopharmaceuticals, Inc. (DAWN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Partners XI Llc Canaan has been a net seller of DAWN stock. They have purchased $208.0K and sold $12.8M worth of shares.
Partners XI Llc Canaan's most recent insider trade was on Sep 20, 2022, when they sold 2,266 shares at $20.10 per share.
Get notified when new Form 4 filings are submitted
| $19.50 |
| Discretionary |
| Sep 19, 2022 | DAWN | $1.6M | Sale | 76,725 | $20.57 | Discretionary |
| Sep 16, 2022 | DAWN | $2.4M | Sale | 111,585 | $21.53 | Discretionary |
| Sep 16, 2022 | DAWN | $82.0K | Sale | 3,722 | $22.04 | Discretionary |
| Sep 15, 2022 | DAWN | $1.1M | Sale | 47,967 | $22.79 | Discretionary |
| Sep 15, 2022 | DAWN | $78.6K | Sale | 3,314 | $23.73 | Discretionary |
| Sep 14, 2022 | DAWN | $2.5M | Sale | 105,727 | $23.68 | Discretionary |
| Sep 14, 2022 | DAWN | $9.3K | Sale | 384 | $24.29 | Discretionary |
| Sep 13, 2022 | DAWN | $2.1M | Sale | 86,644 | $24.39 | Discretionary |
| Sep 13, 2022 | DAWN | $25.1K | Sale | 1,003 | $25.01 | Discretionary |
| Jun 1, 2021 | DAWN | $208.0K | Purchase | 13,000 | $16.00 | Discretionary |
| Jun 1, 2021 | DAWN | $0 | Conversion | 148,279 | $N/A | Discretionary |
| Jun 1, 2021 | DAWN | $0 | Conversion | 7,328,497 | $N/A | Discretionary |